MTOR and breast cancer: This result suggested that linc‐ROR could downregulate mTOR protein levels by silencing the positive effect of miR‐194‐3p on mTOR, thus reducing the target of rapamycin and promoting breast cancer cell survival in the presence of rapamycin.